Neural Stem Cell Therapy for Alzheimer's Disease

V2, Crosslink

🧫

Neural Stem Cell Therapy for Alzheimer's Disease

active

experiment Created: 2026-04-02T10:01:41 By: crosslink-v2 Quality: 67% ✓ SciDEX ID: experiment-exp-wiki-experiments-neural-s

🧫 Experiment Protocol Clinicalproposed

SUMMARY

# Neural Stem Cell Therapy for Alzheimer's Disease ## Background and Rationale Neural stem cell therapy for Alzheimer's disease represents a paradigm-shifting approach to treating one of the most devastating neurodegenerative conditions of our time. This comprehensive Phase I clinical trial addresses a fundamental challenge in Alzheimer's pathophysiology: the progressive loss of neuronal populations coupled with the dramatic decline in endogenous neurogenesis that occurs with aging and disease p

METHODOLOGY NOTES

**Phase 1: Pre-Screening and Baseline Assessment (Weeks -8 to 0)** • Screen 200 patients aged 55-85 with mild-to-moderate AD (MMSE 16-26, CDR 0.5-2.0) • Obtain comprehensive medical history, neurological examination, and safety laboratory panel • Perform baseline cognitive assessment using ADAS-Cog13, MMSE, CDR-SB, and ADCS-ADL • Conduct structural MRI with hippocampal volumetry and DTI sequences • Collect CSF for Aβ42, total tau, p-tau181 biomarkers via lumbar puncture • Perform 18F-florbetapir PET imaging for amyloid burden quantification • Randomize 120 eligible participants 1:1 to treatment vs. sham control groups **Phase 2: NSC Preparation and Quality Control (Week -2)** • Prepare allogeneic human hippocampal NSCs (CTX0E03) at 20×10^6 cells per dose • Conduct sterility testing, mycoplasma screening, and cell viability assessment (>85%) • Verify NSC phenotype markers (Nestin+, SOX2+, GFAP-) via flow cytometry • Perform karyotype analysis and confirm absence of tumorigenic potentia

▸Metadatasource: {'type': 'manual', 'source_name': 'wiki'

source	{'type': 'manual', 'source_name': 'wiki', 'extracted_by': 'backfill_v1', 'extraction_date': '2026-04-16T01:00:16.906421Z'}
summary	# Neural Stem Cell Therapy for Alzheimer's Disease ## Background and Rationale Neural stem cell therapy for Alzheimer's disease represents a paradigm-shifting approach to treating one of the most deva
entities	{'genes': ['ADAS'], 'diseases': ["Alzheimer's Disease"]}
model_system	human
_schema_version	1
experiment_type	clinical
primary_outcome	Validate Neural Stem Cell Therapy for Alzheimer's Disease
methodology_notes	Phase 1: Pre-Screening and Baseline Assessment (Weeks -8 to 0) • Screen 200 patients aged 55-85 with mild-to-moderate AD (MMSE 16-26, CDR 0.5-2.0) • Obtain comprehensive medical history, neurologi
replication_status	single_study
extraction_metadata	{'backfill_at': '2026-04-16T01:00:16.906427', 'needs_review': True, 'extraction_notes': 'Backfilled from wiki source (no PMID available)', 'extraction_confidence': 0.4}

📊 Evidence Profile Foundational

Evidence Balance

+0%

Certainty

100%

Debates

0

Incoming

781

Outgoing

663

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

Neural Stem Cell Therapy for Alzheimer's Disease

derives from (16)

supports (25)

💬 Discussion